XML 31 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Transations

The following table summarizes the stock option transactions for the 2023 Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Options

 

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (years)

 

 

 

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2023

 

 

1,739,270

 

 

$

 

15.71

 

 

 

6.99

 

 

$

 

76

 

Granted

 

 

595,250

 

 

 

 

4.16

 

 

 

10

 

 

 

 

 

Cancelled

 

 

(223,308

)

 

 

 

76.63

 

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

2,111,212

 

 

$

 

6.01

 

 

 

8.34

 

 

$

 

790

 

Vested and exercisable at March 31, 2024

 

 

883,869

 

 

$

 

7.18

 

 

 

6.90

 

 

$

 

356

 

Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the stock option grants

The following are the underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended March 31,

 

 

2024

 

2023

Risk free interest rate

 

2.94%

 

3.56%

Expected volatility

 

89%

 

75%

Expected term (years)

 

6.25

 

6.25

Expected dividend yield

 

0%

 

0%

Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted

Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

171

 

 

$

2,080

 

General and administrative

 

 

243

 

 

 

9,046

 

Total stock-based compensation expense

 

$

414

 

 

$

11,126

 

Schedule of Common Stock Reserved for Future issuance

Common stock reserved for future issuance consists of the following at March 31, 2024:

 

 

 

March 31,

 

 

 

2024

 

Common stock warrants

 

 

6,026,552

 

Stock options issued and outstanding

 

 

2,111,212

 

Shares available for issuance under the 2023 Plan

 

 

91,516

 

Shares available under the 2023 ESPP

 

 

122,545

 

Total

 

 

8,351,825